What Helps with Weight Loss in Diabetes? Evidence-Based Interventions

Tirzepatide → Body weight

Evidence Intelligence™

EvidenceScore™: 84; Strong

Based on 8 studies

Lifestyle intervention for prediabetes → Body weight

Evidence Intelligence™

EvidenceScore™: 82; Strong

Based on 5 studies

Semaglutide → BMI

Evidence Intelligence™

EvidenceScore™: 79; Strong

Based on 4 studies

Empagliflozin → Body weight

Evidence Intelligence™

EvidenceScore™: 79; Strong

Based on 3 studies

Liraglutide → Body weight

Evidence Intelligence™

EvidenceScore™: 79; Strong

Based on 4 studies

Tirzepatide → Waist circumference

Evidence Intelligence™

EvidenceScore™: 77; Strong

Based on 3 studies

Lifestyle intervention for prediabetes → Waist circumference

Evidence Intelligence™

EvidenceScore™: 76; Strong

Based on 4 studies

Dulaglutide → BMI

Evidence Intelligence™

EvidenceScore™: 75; Strong

Based on 3 studies

Explore practical questions View all supporting studies

Select any relationship to review its supporting studies.

Evidence Intelligence™

What the Evidence Shows

A structured summary of where the evidence is strongest, mixed, or still emerging.

Evidence at a Glance

102

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Evidence freshness

May 2026

Latest indexed

Evidence Story

Weight Loss evidence appears to center on Tirzepatide.

Among 102 indexed studies and 63 interventions, the strongest signals are summarized from the available evidence. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: May 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Tirzepatide appears to have a consistent beneficial signal in the indexed evidence.

Evidence basis: 12 evidence pairs - 33 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTs

Tirzepatide

9 studies

EvidenceScore™

84/100

ConsistencyScore™

100/100

Semaglutide

13 studies

EvidenceScore™

88/100

ConsistencyScore™

77/100

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Semaglutide is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Semaglutide

Lifestyle intervention for prediabetes

Semaglutide

13 studies

EvidenceScore™

88/100

ConsistencyScore™

77/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present

Evidence basis: 12 evidence pairs - 30 studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Empagliflozin may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Empagliflozin

Dulaglutide

Empagliflozin

3 studies

EvidenceScore™

79/100

ConsistencyScore™

100/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 11 evidence pairs - 16 studies

Evidence summary for AI and search

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Dediabetes summarizes indexed research evidence for education and discovery. This content is not medical advice and should not replace guidance from a qualified clinician.

Supporting Studies

102

Research documents analyzed

Evidence Pairs

100

Intervention-outcome relationships

Latest Publication

May 2026

Evidence Snapshot

Qualitative overview of the evidence landscape

High Confidence

Based on 102 studies, moderate evidence suggests Semaglutide, Empagliflozin, Tirzepatide are the strongest-supported interventions for weight loss.

Top evidence-backed options for this outcome

Interventions with the strongest supporting evidence in our database

Semaglutide

Studies: 11

Empagliflozin

Studies: 3

Tirzepatide

Studies: 8

Liraglutide

Studies: 4

Lifestyle intervention for prediabetes

Studies: 5

Dulaglutide

Studies: 3

Sitagliptin

Studies: 2

Usual care

Studies: 2

Vitamin D supplementation

Studies: 2

Resistance training

Studies: 2

Note: EvidenceScore™ and ConsistencyScore™ are displayed when meaningful values are available for these aggregate intervention options.

Strongest evidence signals

Key patterns and insights identified across the research landscape

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Moderate positive signal

Semaglutide may improve Body weight

Semaglutide → Body weight

Across 11 studies, Semaglutide shows a consistent moderate positive signal for Body weight.

11 studies

EvidenceScore™: 87.52447552447552/100

Strong positive signal

Tirzepatide shows strong evidence for improving Body weight

Tirzepatide → Body weight

Across 8 studies, Tirzepatide shows a consistent strong positive signal for Body weight.

8 studies

EvidenceScore™: 84.35576923076923/100

Moderate positive signal

Lifestyle intervention for prediabetes may improve Body weight

Lifestyle intervention for prediabetes → Body weight

Across 5 studies, Lifestyle intervention for prediabetes shows a consistent moderate positive signal for Body weight.

5 studies

EvidenceScore™: 82.11047463175122/100

Moderate positive signal

Semaglutide may improve BMI

Semaglutide → BMI

Across 4 studies, Semaglutide shows a consistent moderate positive signal for BMI.

4 studies

EvidenceScore™: 79/100

Moderate positive signal

Liraglutide may improve Body weight

Liraglutide → Body weight

Across 4 studies, Liraglutide shows a consistent moderate positive signal for Body weight.

4 studies

EvidenceScore™: 79/100

Newer diabetes drugs show stronger weight and blood sugar benefits in prediabetes

Practical Questions

Organized using the Dediabetes Evidence Intelligence™ framework.

What improves weight loss?

outcome achievement

Emerging Evidence

Semaglutide, Empagliflozin, and Tirzepatide are among the most studied approaches for Weight Loss.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 13 studies
2
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 9 studies
3
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is based on 102 supporting studies and existing graph evidence signals.

Limitations

Consistency cannot yet be determined.

Applicability

Population details were available for 3 of 102 supporting studies. Reported populations varied; examples included Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between... and 78-year-old man with 40-year T2D history, 31 years insulin-dependent, sarcopenic obesity, extensive cardiovascular disease history, moderate glycemic control (HbA1c 7.0%).

Does Semaglutide improve weight loss?

intervention effectiveness

Strong Evidence

Semaglutide may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 13 studies

Why this answer: This answer is based on 13 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Empagliflozin improve weight loss?

intervention effectiveness

Strong Evidence

Empagliflozin may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Empagliflozin
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 3 studies

Why this answer: This answer is based on 3 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Tirzepatide improve weight loss?

intervention effectiveness

Strong Evidence

Tirzepatide appears to improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 9 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

Semaglutide vs Empagliflozin for weight loss?

compare

Strong Evidence

Semaglutide and Empagliflozin have available evidence for Weight Loss, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 13 studies
2
Empagliflozin
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 3 studies

Why this answer: This answer is based on 16 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

How can I lower body weight?

sub outcome

Emerging Evidence

Semaglutide, Empagliflozin, and Tirzepatide are among the most studied approaches for Body weight.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 11 studies
2
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies
3
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 56 supporting studies and existing graph evidence signals.

Limitations

Consistency cannot yet be determined.

Applicability

Population details were available for 3 of 56 supporting studies. Reported populations varied; examples included Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between... and 78-year-old man with 40-year T2D history, 31 years insulin-dependent, sarcopenic obesity, extensive cardiovascular disease history, moderate glycemic control (HbA1c 7.0%).

What has the strongest evidence for weight loss?

evidence strength

Strong Evidence

Semaglutide, Tirzepatide, and Lifestyle intervention for prediabetes have the strongest available evidence signals in this evidence set.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 13 studies
2
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies
3
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 28 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 28 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

Supporting Research

Selected studies that best represent the evidence behind this topic.

May 16, 2026

Highly relevant

Interventions:

Dapagliflozin Liraglutide Metformin Pioglitazone Semaglutide Tirzepatide

Outcomes:

BMI Body weight

Digital therapy shows comparable effectiveness to in-person weight loss programs

Representative

Interventions:

Vitadio digital therapy

Outcomes:

BMI Body fat mass Waist circumference Weight change

Lifestyle calorie-carbohydrate plans improved type 2 diabetes remission versus usual care

May 26, 2026

Recent

Interventions:

Calorie restriction Low-carbohydrate diet

Outcomes:

Body fat mass Body weight

Remote nutrition education with low-carb diet improves blood sugar and reduces medication use in type 2 diabetes

May 4, 2026

Recent

Interventions:

Low-carbohydrate diet

Outcomes:

BMI Body weight

Synbiotics improve health in elderly with diabetes

Representative

Interventions:

Synchronous online type 1 diabetes psychoeducational program for school staff

Outcomes:

Body Mass Index (BMI) change Body fat mass (BFM) change Weight change

Lifestyle changes may improve diabetes remission rates

Representative

Interventions:

Complex lifestyle intervention

Outcomes:

Body Mass Index (BMI) change Waist-to-hip ratio Weight change